Karuna Therapeutics

Karuna Therapeutics is backed by in-depth expertise in neuroscience and a strong capacity for innovation in research and development.

Karuna is the Sanskrit word for compassion in action, to alleviate the suffering of others. This is the company's vision: to transform the treatment of mental illness in order to improve the lives of those so deserving of compassion.

Based in the U.S., the company is working on the development of drugs that can bring significant relief to patients suffering from psychiatric and neurological disorders, with a particular focus on schizophrenia and the behavioral symptoms associated with Alzheimer's disease.